| 2021-01-18 | subclass updated from VUS4 to VUS2 |
Variant NM_000492.4:c.902A>G
| Name | NM_000492.4:c.902A>G |
| Protein name | NP_000483.3:p.(Tyr301Cys) |
| Genomic name (hg19) | chr7:g.117180186A>G UCSC |
| Genomic name (hg38) | chr7:g.117540132A>G UCSC |
| #Exon/intron | exon 8 |
| Legacy Name | Y301C |
| Class | VUS |
| Subclass | VUS |
| WT sequence | CTGAAACTGACTCGGAAGGCAGCCT A TGTGAGATACTTCAATAGCTCAGCC |
| Mutant sequence | CTGAAACTGACTCGGAAGGCAGCCT G TGTGAGATACTTCAATAGCTCAGCC |
![]() | ![]() Not found | dbSNP rs150691494 |
![]() | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| ELX-TEZ-IVA | yes | no | yes | no |
| VNZ-TEZ-DIVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 3 |
|---|---|
| Asymptomatic compound heterozygote | 2 |
| CFTR-RD | 1
|
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Asymptomatic compound heterozygote | 5245 | heterozygote | VUS3 - Trans |
| Asymptomatic compound heterozygote | 5255 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 4487 | heterozygote |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|